Evidence suggests that small subpopulations of tumor cells maintain a unique self-renewing and differentiation capacity and may be responsible for tumor initiation and/or relapse. Clarifying the mechanisms by which these tumor-initiating cells (TICs) support tumor formation and progression could lead to the development of clinically favorable therapies. Ovarian cancer is a heterogeneous and highly recurrent disease. Recent studies suggest TICs may play an important role in disease biology. We have identified culture conditions that enrich for TICs from ovarian cancer cell lines. Growing either adherent cells or non-adherent 'floater' cells in a low attachment plate with serum free media in the presence of growth factors supports the propagation of ovarian cancer TICs with stem cell markers (CD133 and ALDH activity) and increased tumorigenicity without the need to physically separate the TICs from other cell types within the culture. Although the presence of floater cells is not common for all cell lines, this population of cells with innate low adherence may have high tumorigenic potential.Compared to adherent cells grown in the presence of serum, TICs readily form spheres, are significantly more tumorigenic in mice, and express putative stem cell markers. The conditions are easy to establish in a timely manner and can be used to study signaling pathways important for maintaining stem characteristics, and to identify drugs or combinations of drugs targeting TICs. The culture conditions described herein are applicable for a variety of ovarian cancer cells of epithelial origin and will be critical in providing new information about the role of TICs in tumor initiation, progression, and relapse.
Introduction
Ovarian cancer is the most lethal gynecological malignancy in the United States with the major cause of morbidity and mortality being the highly recurrent, chemoresistant features of this disease. Primary treatment usually comprises maximal cytoreductive surgery and subsequent platinum based therapy, although there is some evidence to suggest neoadjuvant therapy might be beneficial in some cases 1 . The majority of patients respond favorably to primary treatment, but unfortunately half will relapse within 18 months 2 .
Most ovarian malignancies are epithelial carcinomas and may originate in the surface epithelia of the ovary or fallopian tube 3, 4 . Several studies support the existence of somatic stem cells in the female reproductive system that presumably assist in tissue repair that is needed following ovulation 5, 6 . The high proliferative activity at both the ovary and fallopian tube during ovulation might be an important factor in the development of ovarian cancer (Gharwan, et al. manuscript submitted). The derivation of tumor-forming cells is unclear but they may arise from normal stem cells, progenitor cells, or differentiated cells through mutations that render them unable to regulate division or fate. These cells have also been termed "cancer stem cells," or "cancer-initiating cells," and can grow into tumorigenic, multicellular spheroids under low attachment conditions. Although the hierarchical model of TIC development may be dynamic, TICs do share many of the same features as normal stem cells including quiescence, resistance to chemotherapy, long-term self-renewal and ability to differentiate into various cell lineages 7, 8 .
Several studies support the existence of TICs in ovarian cancer and current efforts are underway to clarify the mechanism(s) by which these cells support tumorigenesis [9] [10] [11] . Several markers have been proposed to identify ovarian TICs with enhanced tumorigenicity including CD133, ALDH1A1, CD117, CD44, and MyD88, although the exact contribution of each marker is unclear and may be cell type specific [11] [12] [13] [14] [15] [16] . While a universal marker or set of markers has not been unequivocally established for ovarian TICs, different groups have isolated ovarian TICs more commonly by selecting for CD44+, CD133+ and/or cells with high aldehyde dehydrogenase (ALDH) activity 13, [17] [18] [19] [20] [21] . CD44 is a transmembrane glycoprotein that acts as a receptor for hyaluronic acid and regulates several processes important for tumor progression, including adhesion, proliferation, migration, angiogenesis and differentiation 22 . CD133 is a transmembrane glycoprotein whose function is still unclear but studies suggest it organizes plasma membrane topology 23 . ALDH, an intracellular enzyme that catalyzes the oxidation of aldehydes, may be the most universal marker of TICs as high activity has been identified in stem cells isolated from a variety of tissues and multiple roles have been attributed to ALDH in supporting normal stem cells and TICs 24 . As of now, CD133 and ALDH1 appear to be the most reproducible markers of ovarian TICs 13, 21 .
In addition to understanding the characteristics of TICs, there is also a large effort to identify drugs that specifically target this subpopulation. The high relapse rate associated with ovarian cancer may be due to the failure of current chemotherapies to successfully eradicate TICs. Although . Although there are several stem cell culture medias and supplements commonly used for enriching TICs/spheroids we used a serum-free media formula with EGF and FGF, but without the addition of B27 or N-2 supplements. These supplements, commonly used for neuronal cell culture and enriching for stem cells, have been shown to promote a mesenchymal phenotype 25, 26 and there remains some uncertainty in the field as to whether TICs having a mesenchymal or epithelial phenotype are more tumorigenic [27] [28] [29] .
To minimize uncertainties and variables we opted to use the most common formula, since we are dealing with epithelial ovarian cancer cells.
Maintaining cells in serum-free media in a low attachment flask facilitates spheroid formation and supports the propagation of cells with CD133 expression and high ALDH activity. Our work has further showed that cells floating under normal adherent conditions can also represent a more tumorigenic TIC population. Injection of cells grown in these conditions into athymic nude mice leads to higher tumorigenic potential compared to cells grown in attached conditions in the presence of serum. Much information regarding the role of TICs in ovarian cancer initiation, progression, therapeutic response, and disease relapse can be gained through the use of these techniques. 
Generation of Multicellular Spheroids from Ovarian Cancer Cell Lines Using Floating or Adherent Cells
NOTE: All handling of cells and media should take place in a sterile tissue culture hood. After culturing cell lines under traditional culture methods for 2 -3 passages (section 1) proceed with the following steps.
1. Prepare stem cell media. Use 1:1 DMEM:F12 (+ L-glutamine, + 15 mM HEPES) and supplement with 1% penicillin/streptomycin (to a final concentration of 100 U/ml penicillin and 100 µg/ml streptomycin), 1% knockout serum replacement, 0.4% bovine serum albumin, and 0.1% insulin-transferrin-selenium. Filter solution using 0.45 µm vacuum filter. 2. Supplement stem cell media with human recombinant epidermal growth factor (EGF) and human recombinant basic fibroblast growth factor (FGF) for a final concentration of 20 ng/ml and 10 ng/ml, respectively. NOTE: Growth factors should be added fresh to the stem cell media right before use. Add 10 ml stem cell media, supplemented with EGF and FGF, as described, to the flask. 8. Add 6 ml stem cell media to the flask with the trypsin. Pipet cell solution up and down and attempt to loosen cells from the flask surface.
Transfer entire volume of cells to ultra low attachment flask containing the 10 ml stem cell media. Place flask in humidified cell culture incubator set to 37 °C and 5% CO 2 . 9. Supplement TIC cultures every 48 -72 hr with an additional 2 ml stem cell media and fresh EGF and FGF for final concentrations of 20 ng/ml and 10 ng/ml, respectively. 10. Monitor cells until 60 -80% confluence is reached. Split cultures by placing equal volumes into 2 new ultra low attachment flasks and adding fresh stem cell media to achieve a final volume of 18 ml. Alternatively, centrifuge the entire suspension at 4 °C for 5 min at 400 x g. Resuspend cells in stem cell media supplemented with EGF and FGF and distribute equally into new ultra-low attachment flasks. Cells do not have to be dissociated into single cell suspensions for passaging. NOTE: At this point the cultures can continue to be split and cultured, frozen, or experimentally manipulated for analysis. At 60 -80% confluence the following concentrations of cells were retrieved for ACI-23: 8.0 x 10 6 for Traditional Adherent, 4.0 x 10 6 for Traditional TIC, and 5.0 x 10 6 for Floater TIC cultures. Although it might be cell line dependent, we have found that 5 -10 days in culture is optimal for TIC enrichment as the percentage of CD133+ALDH+ cells is low within the first 3 days, peaks at 5 -10 days, and diminishes again at 14 days.
Generation of Primary Epithelial Ovarian Cancer Cell Lines and Multicellular Spheroids from Chemoresistant Patient Ascites
NOTE: Institutional Review Board approval was obtained for this protocol. All handling of cells and media should take place in a sterile tissue culture hood.
1. Plate ascites fluid 1:1 with traditional cell culture media. Prepare media as described in section 1 and add 10 ml to several traditional polystyrene 75 cm 2 tissue culture flasks.
2. Ascites fluid is usually provided in 1 L sterile vacuum bottles; remove vacuum cap. Carefully add 10 ml ascites fluid to flask containing 10 ml traditional media and place in humidified cell culture incubator set to 37 °C and 5% CO 2 . Leave undisturbed for 72 -96 hr, before doing a complete media change. Change media every 2 -3 days until cells reach 60 -80% confluence 3. Once cells reach 60 -80% confluence, split 1:2 as described in section 1. Start TIC cultures as described in section 2.
NOTE: Erythrocytes present in ascites will be removed after the first media change as they are non-adherent. Any fibroblasts present will be largely removed after treatment with trypsin as they are more sensitive and will lift with minimal exposure to trypsin. Purity of ovarian cancer cells was determined by flow cytometry analysis using antibody for CA-125 (MUC16). 
Staining of Cells for Flow Cytometry Confirmation of TIC Markers

In vivo Subcutaneous Injections to Confirm Tumorigenicity of Cell Populations
NOTE: Institutional Review Board approval was obtained for this protocol. Distribute athymic female nude mice 6 -8 weeks of age into experimental groups in cages of 3 and allow to acclimate for a few days prior to injections. Follow mice under humane experimental guidelines as per NIH Animal Care and Use Committee; monitor body weight, physical appearance including weight loss or gain greater than 20%, emaciated appearance, diarrhea or dermatitis and euthanize mice fitting these criteria by CO 2 asphyxia.
1. Collect cultures as described in section 2. Resuspend each cell population in 1 ml PBS. Count viable cells using trypan blue assay. NOTE: Although this study compared tumorigenicity of TICs versus adherent cells for the first generation only, in vivo serial passaging of TICs grown under similar conditions has been completed by others 11, 20 .
Representative Results
Established ovarian cancer cell lines and a primary ascites cell line grown in traditional adherent culture conditions in the presence of serum show attached, cobblestone morphology, whereas the same cells grown in TIC culture conditions display floating spheroid morphology, common in TIC populations. Brightfield images displayed in Figure 1A clearly show the morphological differences in the culture conditions. Figure 1B shows the differentiated morphologies achieved after replating the ACI-23 and TGS-3 TIC cultures in traditional adherent conditions. Just 24 hr after seeding back in adherent conditions, a majority of the multicellular spheroids dissociate and attach to the surface, resembling typical adherent cells.
To verify that the TIC conditions enrich for cells with stem cell markers flow cytometry analysis was performed using two common markers of ovarian TICs -CD133 expression and ALDH activity. Dot plots shown in Figure 2A highlight the increased percentage of CD133+ cells in low attachment, serum-free conditions. Similarly, the activity of the ALDH enzyme is higher in these conditions compared to traditional adherent culture conditions. Although the traditional adherent cultures contain CD133+ cells, the percentage increases under conditions that enhance spheroid formation. Analysis of a pluripotency marker, TRA-1-60, lends further support that the TIC conditions enrich for TICs, Figure 2B . Quantification in Figure 2C demonstrates that double positive (CD133+ALDH+) ACI-23 cells are largely limited to cultures grown under TIC enhancing conditions. Changes in the protein levels of different transcriptional factors that occur in the ACI-23 cells after five days of culture in the TIC conditions were also examined. A progressive increase in each of the markers is seen from traditional to floater TIC conditions compared to the relatively low levels seen in the adherent culture, Figure 2D . Interestingly a human ascites cell line grown in the various conditions displays the highest marker phenotype under the traditional TIC conditions with little to no staining present in the floater TIC conditions, Figure  2E .
The tumorigenicity of the TIC culture conditions was validated through subcutaneous injections of equal numbers of viable cells obtained from all conditions into cohorts of athymic nude mice. It is important to keep in mind, however, that the expression of TIC markers, such as CD133, CD44, or ALDH, may vary among cell lines or patient samples even of the same tumor type. For example we found that the OVCAR-5 cells have higher expression of CD44 relative to CD133, whereas the inverse is true for ACI-23. It is therefore pertinent to rely on tumor initiation in mice and flow cytometry analysis as definitive of TIC presence. Following this protocol, high ALDH activity was consistently observed when ovarian cancer cells were grown in stem cell conditions. Interestingly, CD133 expression is consistently higher in ACI-23 cells grown in traditional TIC culture conditions, whereas ALDH is highest in floater TIC conditions. In contrast the TGS-3 primary ascites cells display a small increase in CD133 positivity under floater TIC conditions, but a remarkable increase in ALDH activity under traditional TIC conditions. These findings highlight the heterogeneity of ovarian cancer cells and the plasticity commonly associated with TICs. To further support the claim that these methods enhance TICs, the enrichment of TRA-1-60 positive cells was also observed. TRA-1-60 is a pluripotency marker and has been used to identify embryonal carcinomas of the ovary and testes as well as prostate cancer TICS [30] [31] [32] . Although our methods have been successful with numerous cell lines, it is possible that the standard TIC conditions might be better suited to some ovarian cancer cells, while the modified floater conditions better enrich for TICs in other ovarian cancer cell populations. This again underscores the expected heterogeneity within both patient-derived and established ovarian cancer cell lines.
In addition to cell surface markers there are several transcriptional factors that have been shown to characterize ovarian cancer TICs including Nanog, Sox2, Oct-4 11 , although these markers are not specific to ovarian cancer TICs and rather represent factors important for embryonic stem cell pluripotency and differentiation 33, 34 . We examined the changes in protein levels of these factors and found that Nanog levels increase in TIC culture conditions, in agreement with others 13, 35 as well as CD133, TRA-1-60, and CD117. A human stem cell marker cDNA array further showed an increase in CD133, Nanog, Melk, and PODXL genes in the TIC conditions compared to traditional adherent conditions. Importantly, it should be noted that, as with cell surface markers, transcriptional factors associated with ovarian TICs may vary among cell lines and patient samples.
We have observed that cells may be more tumorigenic and express higher levels of stem cell markers if they are inherently non-adherent in vitro (i.e., floating cells that do not readily attach to an adherent plate). In culture, cell lines such as ACI-23 typically have many viable floating cells and/or cells that grow vertically in a stacking fashion under traditional culture conditions. Although successful enrichment of TICs from floating cells and aggregates might be applicable to relatively few cell lines including those in the present study and OVCAR-3 12 , our findings suggest this might represent a more tumorigenic population. Therefore, harvesting the "floating" population of cells grown in standard tissue culture plates and media may serve as an alternate method of TIC enrichment, for cells that adapt poorly to commercial stem cell media.
Use of the different culture methods presented in this manuscript will enable quick enrichment of TIC populations and a better understanding of what factors support this phenotype in different cells. Current applications of this method include characterizing which signaling pathways are vital to support the propagation of this unique population of cells. Results from these studies will help to clarify mechanisms of tumor progression and relapse.
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